Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Finished Goods (2015 - 2022)

Talphera (TLPH) posted Finished Goods of $44000.0 for Q4 2022, down 56.44% on a QoQ basis from $101000.0 in Q3 2022, and down 80.87% year-over-year from $230000.0 in Q4 2021.

Analysis

Talphera (TLPH) Finished Goods (2015 - 2022) Analysis & Trends

Talphera has reported Finished Goods for 7 years, with the latest figure at $44000.0 in Q4 2022.

  • On a quarterly basis, Finished Goods fell 80.87% year-over-year to $44000.0 in Q4 2022; TTM through Dec 2022 was $44000.0, a 80.87% decrease from a year earlier, with the FY2022 full-year figure at $44000.0, down 80.87% from the prior year.
  • Finished Goods was $44000.0 for Q4 2022 at Talphera, down from $101000.0 in the prior quarter.
  • The five-year high for Finished Goods was $2.0 million in Q1 2020, with the low at $44000.0 in Q4 2022.
  • Average Finished Goods over 4 years is $931562.5, with a median of $997500.0 recorded in 2021.
  • The sharpest annual moves came in 2020 and 2022: Finished Goods surged 289.82% in 2020, then slumped 88.89% in 2022.
  • Over 4 years, Finished Goods stood at $1.5 million in 2019, then retreated by 13.56% to $1.3 million in 2020, then sank by 82.82% to $230000.0 in 2021, then sank by 80.87% to $44000.0 in 2022.
  • The last three Finished Goods figures came in at $44000.0 (Q4 2022), $101000.0 (Q3 2022), and $221000.0 (Q2 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Talphera 92.90 Mn 92.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 44,000.00
Sep 30, 2022 101,000.00
Jun 30, 2022 221,000.00
Mar 31, 2022 359,000.00
Dec 31, 2021 230,000.00
Sep 30, 2021 909,000.00
Jun 30, 2021 1.09 Mn
Mar 31, 2021 1.26 Mn
Dec 31, 2020 1.34 Mn
Sep 30, 2020 1.52 Mn
Jun 30, 2020 1.95 Mn
Mar 31, 2020 1.95 Mn
Dec 31, 2019 1.55 Mn
Sep 30, 2019 744,000.00
Jun 30, 2019 1.15 Mn
Mar 31, 2019 501,000.00
Jun 30, 2017 200,000.00
Mar 31, 2017 681,000.00
Dec 31, 2016 732,000.00
Sep 30, 2016 175,000.00